Babylon is a world leading, digital-first, value-based care company whose mission is to make high-quality healthcare accessible and affordable for everyone on Earth. Babylon is re-engineering healthcare, shifting the focus from sick care to preventative healthcare so that patients experience better health, and reduced costs. This is achieved by leveraging a highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare. Babylon endeavors to support patients’ health needs, all from their devices, with the aim to promote longer and healthier lives. When sick, Babylon provides assistance to navigate the health system, connecting patients digitally to the right clinician 24/7, at no additional cost. Founded in 2013, Babylon has since delivered millions of clinical consultations and AI interactions, with c.2m clinical consultations and c.3.9m AI interactions in 2020 alone. Babylon works with governments, health providers and insurers across the globe, and support healthcare facilities from small local practices to large hospitals.
Company profile
Ticker
BBLN
Exchange
Website
Employees
Location
Sector
Industry (SIC)
SEC CIK
BBLN stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Results of Operations and Financial Condition
12 Jan 23
6-K
Babylon Announces Additional Details on its Upcoming 1-for-25 Reverse Share Split
8 Dec 22
424B3
Prospectus supplement
6 Dec 22
EFFECT
Notice of effectiveness
6 Dec 22
EFFECT
Notice of effectiveness
6 Dec 22
424B3
Prospectus supplement
5 Dec 22
CORRESP
Correspondence with SEC
1 Dec 22
UPLOAD
Letter from SEC
30 Nov 22
POS AM
Prospectus update (post-effective amendment)
29 Nov 22
F-3
Shelf registration (foreign)
23 Nov 22
Latest ownership filings
3
David James Humphreys
11 Jan 23
3
DAVID P WARREN
11 Jan 23
3
Paul-Henri Ferrand
10 Jan 23
3
Ali Parsadoust
10 Jan 23
3
Darshak Sanghavi
10 Jan 23
3
Mairi Johnson
10 Jan 23
3
Per Brilioth
4 Jan 23
3
Georgi Ganev
4 Jan 23
3
Mohannad AlBlehed
3 Jan 23
3
Initial statement of insider ownership
3 Jan 23
Financial summary
| Quarter (USD) | Dec 21 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Annual (USD) | Dec 21 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
Institutional ownership, Q3 2021
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
News
Stocks That Hit 52-Week Lows On Tuesday
27 Dec 22
Stocks That Hit 52-Week Lows On Wednesday
21 Dec 22
Babylon Announces Additional Details On Its Upcoming 1-For-25 Reverse Share Split
8 Dec 22
12 Health Care Stocks Moving In Thursday's After-Market Session
8 Dec 22
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
1 Dec 22
Press releases
Babylon Delivers Strong 2022 Results, Beating Expectations
12 Jan 23
Babylon Announces Additional Details on its Upcoming 1-for-25 Reverse Share Split
8 Dec 22
Babyl & Novo Nordisk partner to provide an innovative approach to diabetes awareness and care in Rwanda
1 Dec 22
Babylon to Provide Fitbits, Expand Access to Proactive Monitoring for Eligible Members
15 Nov 22
Babylon Reports Another Strong Quarter Ahead of Consensus Estimates with Revenue Growth of 3.9x and 45 ppts Adjusted EBITDA Margin Improvement
10 Nov 22